Olema Pharmaceuticals, Inc. OLMA 深 滬
等待開盤 03-26 09:30:00 美东时间
14.17
+0.240
+1.72%
華盛通- 最 高14.38
- 今 開14.09
- 成交量 138.62万股
- 最 低 13.98
- 昨 收 13.93
- 總市值 11.15亿
- 52周最高 36.2591
- 市盈率 靜 --
- 換手率 1.76%
- 52周最低 2.86
- 委 比 93.57%
- 總股本 7865.99万
- 歷史最高 60.27
- 量 比 0.49
- 振 幅 2.87%
- 歷史最低 2.00
- 每 手 1
- 風險率 9.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Nvidia To Rally Around 79%? Here Are 10 Top Analyst Forecasts For Wednesday
Top analysts changed outlook on top names. Mizuho, Needham, Rothschild & Co, HC Wainwright & Co, Stifel, BTIG, Goldman Sachs made changes.
03-18 20:19
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Guggenheim Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $38
Guggenheim analyst Brad Canino maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $40 to $38.
03-17 20:57
Olema Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 ESP results.
Olema Pharmaceuticals shares are trading higher after the company reported bett...
03-17 00:50
财报速睇 | Olema Pharmaceuticals 2025财年年度营收0.00亿美元，同比增长0.0%；归母净利润亏损1.62亿美元，同比亏损扩大25.6%
华盛资讯3月16日讯，Olema Pharmaceuticals公布2025财年年度业绩，公司年度营收0.00亿美元，同比增长0.0%，归母净利润亏损1.62亿美元，同比亏损扩大25.6%。
03-16 19:32
Olema Pharmaceuticals Q4 EPS $(0.50) Beats $(0.53) Estimate
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.53) by 6.19 percent. This is a 1.96 percent increase over losses of $(0.51) per share
03-16 19:20
财报速睇 | Olema Pharmaceuticals 2025财年Q4营收0.00亿美元，同比增长0.0%；归母净利润亏损0.46亿美元，同比亏损扩大37.2%
华盛资讯3月16日讯，Olema Pharmaceuticals公布2025财年Q4业绩，公司Q4营收0.00亿美元，同比增长0.0%，归母净利润亏损0.46亿美元，同比亏损扩大37.2%。
03-16 19:17
Olema Q4 net loss widens 37.2% to USD 46.06 million
Olema Q4 net loss widens 37.2% to USD 46.06 million Olema published a quarterly and annual earnings press release reporting fourth-quarter and full-year 2025 financial and operating results. Q4 net loss widened 37.2% to USD 46.06 million. FY net loss widened 25.5% to USD 162.45 million, driven by hi
03-16 19:03
